This is evidenced that in angiotensin II mouse model, functional S1PR1 antagonism using fingolimod‐reduced S1PR1 expression in mouse endothelium and thus exacerbated hypertension, highlighting the potential harmful effects of fingolimod on vascular function.61 This evidence concerns the gene AGT and hypertensive disorder.